Small GTP-binding protein Ral is involved in cAMP-mediated release of von Willebrand factor from endothelial cells

Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1315-20. doi: 10.1161/01.ATV.0000131267.13425.45. Epub 2004 May 6.

Abstract

Objective: von Willebrand factor (vWF) is synthesized by endothelial cells and stored in specialized vesicles called Weibel-Palade bodies (WPBs). Recently, we have shown that the small GTP-binding protein Ral is involved in thrombin-induced exocytosis of WPBs. In addition to Ca2+-elevating secretagogues such as histamine and thrombin, release of WPB is also observed after administration of cAMP-raising substances such as epinephrine and vasopressin. In the present study, we investigated whether Ral is also involved in cAMP-mediated vWF release.

Methods and results: Activation of Ral was observed 15 to 20 minutes after stimulation of endothelial cells with epinephrine, forskolin, or dibutyryl-cAMP. A cell-permeable peptide comprising the carboxy-terminal part of the Ral protein reduced both thrombin-induced and epinephrine-induced vWF secretion supporting a crucial role for Ral in this process. Furthermore, inhibition of protein kinase A by H-89 resulted in a marked reduction of vWF release and greatly diminished levels of GTP-Ral on stimulation with epinephrine. Activation of Ral was independent of the activation of Epac, a cAMP-regulated exchange factor for the small GTPases Rap1 and Rap2.

Conclusions: These results suggest that protein kinase A-dependent activation of Ral regulates cAMP-mediated exocytosis of WPB in endothelial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bucladesine / pharmacology
  • Cells, Cultured / drug effects
  • Cells, Cultured / metabolism
  • Colforsin / pharmacology
  • Cyclic AMP / analogs & derivatives*
  • Cyclic AMP / pharmacology
  • Cyclic AMP / physiology
  • Cyclic AMP-Dependent Protein Kinases / physiology*
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / metabolism*
  • Epinephrine / pharmacology
  • Exocytosis / drug effects*
  • Gene Products, tat / physiology
  • Humans
  • Peptide Fragments / pharmacology
  • Phosphorylation
  • Protein Processing, Post-Translational
  • Second Messenger Systems / drug effects
  • Second Messenger Systems / physiology
  • Thionucleotides / pharmacology
  • Thrombin / pharmacology
  • Umbilical Veins
  • Vasopressins / pharmacology
  • Weibel-Palade Bodies / drug effects
  • Weibel-Palade Bodies / metabolism*
  • ral GTP-Binding Proteins / physiology*
  • von Willebrand Factor / metabolism*

Substances

  • Gene Products, tat
  • Peptide Fragments
  • Thionucleotides
  • von Willebrand Factor
  • Vasopressins
  • Colforsin
  • 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP
  • Bucladesine
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
  • Thrombin
  • ral GTP-Binding Proteins
  • Epinephrine